Multiple myeloma
Alternate Names : Plasma cell dyscrasia, Plasma cell myeloma, Malignant plasmacytoma, Plasmacytoma of bone, Myeloma - multiple
Treatment
The goal of treatment is to relieve symptoms. People who have mild disease or a questionable diagnosis are usually carefully monitored without treatment. Some people have a slow-developing form of multiple myeloma that takes years to cause symptoms. Treatment begins when the disease becomes worse or causes symptoms.
Chemotherapy and radiation therapy may be performed to relieve bone pain or treat a bone tumor. Bone marrow transplantation in younger patients has been shown to increase disease-free and overall survival, but it has significant risks. Medications for multiple myeloma include decadron, melophalan, thalidomide, lenalidomide (Revlimid), and bortezomib (Velcade). Bisphosphonates are used to prevent fractures. People with multiple myeloma should drink plenty of fluids to prevent dehydration and help maintain proper kidney function. They should also be cautious when having x-ray tests that use contrast dye. Chemotherapy and transplants rarely lead to a permanent cure.
Support Groups
The stress of illness may be eased by joining a support group whose members share common experiences and problems. See: Cancer - support group
Prognosis (Expectations)
Survival of people with multiple myeloma depends on the patient's age and the stage of disease. Some cases are very aggressive, while others take years to get worse.
Complications
Kidney failure is a frequent complication. Other complications may include:
Calling Your Health Care Provider
Call your health care provider if you experience decreased urine output. Call your provider if you have multiple myeloma and infection develops, or numbness, loss of movement, or loss of sensation develops.
|
Previous
